Vertex Pharmaceuticals remains on hold with a $494 price target from Stifel analysts after discussions about its chronic pain ...

Vertex Pharmaceuticals is making waves with its new pain treatment, Journavx, which is experiencing a prescription growth ...

Shares of Vertex Pharmaceuticals Inc. VRTX rose 3.38% to $439.37 Monday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index SPX rising 3.26% to 5 ...

Henry looks at the M36 field watch from Vertex ✓ A British brand with a rich heritage. Vertex was founded in 1916 ✓ ...